International Journal of Telemedicine and Applications

Research Article

Comparison of Goal Achievement during an Early, Intensive Nutrition Intervention Delivered to People with Upper Gastrointestinal Cancer by Telephone Compared with Mobile Application

Table 2

Demographic data at baseline by intervention group.
Demographic dataMobile app ()Telephone ()
Age year mean (sd)66.6 (9.7)67.5 (10.3)
Gender (%)
 Male26 (72%)25 (66%)
 Female10 (28%)13 (34%)
Cancer type (%)
 Oesophageal17 (47%)16 (42%)
 Pancreatic10 (28%)18 (47%)
 Gastric9 (25%)4 (11%)
Weight mean (sd)76.4 (14.7)71.9 (12.7)
MST score mean (sd)2.78 (1.94)2.72 (2.18)
PG-SGASF score mean (sd)8.5 (6.5)8.5 (6.2)
EQ-5D-5L–median (IQR)
 Mobility (0-100, higher scores equal more difficulty with task completion)1 (1.3)1 (1.1)
 Self-care (0-100, higher scores equal more difficulty with task completion)1 (1.1)2 (1.2)
 Usual activities (0-100, higher scores equal more difficulty with task completion)2 (1.2)1 (1.1)
 Pain or discomfort (0-100, higher scores equal higher severity of symptoms)1 (1.1)1 (1.2)
 Anxiety or depression (0-100, higher scores equal higher severity of symptoms)2 (1.2)2 (1.3)
EQ-5D-5L-utility score–mean (sd) (0-100, higher scores better QoL)0.65 (0.20)0.71 (0.23)
EQ-5D-5L-visual analogue scale–mean (sd) (0-100, higher scores better QoL)62.08 (22.01)65.04 (22.9)
EORTC QLQ-C30 score–mean (sd)
 Global health (0-100, higher scores better QoL)63.51 (36.61)79.28 (25.72)
 Physical functioning (0-100, higher scores better QoL)72.52 (29.71)83.33 (21.52)
 Role functioning (0-100, higher scores better QoL)27.93 (27.51)10.81 (21.59)
 Emotional functioning (0-100, higher scores better QoL)26.13 (30.60)46.85 (36.39)
 Cognitive functioning (0-100, higher scores better QoL)81.23 (20.08)63.41 (26.17)
 Social functioning (0-100, higher scores better QoL)85.09 (18.90)72.15 (21.26)
 Fatigue (0-100, higher scores more symptoms)11.84 (20.47)35.38 (29.21)
 Nausea and vomiting (0-100, higher scores more symptoms)28.95 (29.17)13.16 (23.94)
 Pain (0-100, higher scores more symptoms)61.22 (24.60)17.54 (28.72)
 Dyspnoea (0-100, higher scores more symptoms)73.38 (25.34)65.28 (35.04)
 Insomnia (0-100, higher scores more symptoms)42.90 (31.44)74.07 (32.96)
 Appetite loss (0-100, higher scores more symptoms)12.96 (18.30)26.63 (33.36)
 Constipation (0-100, higher scores more symptoms)22.22 (31.87)28.70 (35.77)
 Diarrhoea (0-100, higher scores more symptoms)7.02 (22.13)10.81 (22.30)
 Financial difficulties (0-100, higher scores more symptoms)16.66 (40.19)4.63 (19.76)
EQ-5D-5L: EuroQol 5D-5L instrument [26]; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Question–Core 30 [25]; PG-SGA: Patient-Generated Subjective Global Assessment [24]; sd: standard deviation; MST: Malnutrition Screening Tool [20]; LGTBQI+: lesbian, gay, transexual, bisexual, queer, intersex+.